ArticleInternational journal of molecular sciences2023

Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Max Bermes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.